Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | E754F | — |
Shingrix vaccine had been incorrectly reconstituted, using saline solution; Shingrix vaccine had been incorrectly reconstituted, using saline solution; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 53-year-old male patient who received Herpes zoster (Shingrix) (batch number E754F, expiry date 31-MAR-2027) for prophylaxis. On 16-MAY-2025, the patient received Shingrix. On 16-MAY-2025, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: Shingrix vaccine had been incorrectly reconstituted, using saline solution) and inappropriate dose of vaccine administered (Verbatim: Shingrix vaccine had been incorrectly reconstituted, using saline solution). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 16-MAY-2025 On 16th May 2025, a registered nurse had called to report that a Shingrix vaccine had been incorrectly reconstituted using saline solution and had been administered to a patient on the same day, which led to wrong solution used in drug reconstitution and Inappropriate dose of vaccine administered.